Outcomes | Groups | Baseline | Assessment at 6th Week | Assessment at 12th Week | Follow up at 16th Week |
Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
Tremors | VR + RPT | 6.350 ± 1.039 | 4.600 ± 1.667 | 3.300 ± 1.301 | 4.450 ± 1.276 |
MI + RPT | 5.850 ± 1.308 | 4.800 ± 1.823 | 4.150 ± 1.565 | 4.500 ± 1.317 | |
RPT | 6.000 ± 1.521 | 5.650 ± 1.565 | 4.850 ± 1.565 | 5.650 ± 1.460 | |
F | 0.773 | 2.18 | 5.482 | 5.027 | |
p-value | 0.466 | 0.122 | 0.007 | 0.01 | |
Rigidity | VR + RPT | 4.950 ± 0.604 | 3.700 ± 1.031 | 2.750 ± 1.251 | 2.850 ± 1.136 |
MI + RPT | 4.550 ± 0.998 | 4.300 ± 1.128 | 3.600 ± 1.391 | 3.700 ± 1.625 | |
RPT | 4.650 ± 0.875 | 4.200 ± 1.005 | 4.050 ± 1.503 | 4.100 ± 1.803 | |
F | 1.221 | 1.852 | 4.537 | 3.402 | |
p-value | 0.302 | 0.166 | 0.015 | 0.04 | |
Bradykinesia | VR + RPT | 1.950 ± 0.510 | 1.700 ± 0.470 | 0.950 ± 0.510 | 1.050 ± 0.604 |
MI + RPT | 1.850 ± 0.366 | 1.750 ± 0.444 | 1.550 ± 0.604 | 1.550 ± 0.604 | |
RPT | 1.950 ± 0.223 | 1.950 ± 0.223 | 1.350 ± 0.745 | 1.450 ± 0.686 | |
F | 0.45 | 2.242 | 4.739 | 3.492 | |
p-value | 0.64 | 0.116 | 0.012 | 0.037 |